CONMED Management

Management Kriterienprüfungen 3/4

CONMED's CEO ist Curt Hartman , ernannt in Jul 2014, hat eine Amtszeit von 9.92 Jahren. Die jährliche Gesamtvergütung beträgt $7.76M , bestehend aus 12.2% Gehalt und 87.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.29% der Aktien des Unternehmens, im Wert von $6.18M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 9.1 Jahre bzw. 8.9 Jahre.

Wichtige Informationen

Curt Hartman

Geschäftsführender

US$7.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts12.2%
Amtszeit als Geschäftsführer9.9yrs
Eigentum des Geschäftsführers0.3%
Durchschnittliche Amtszeit des Managements9.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder8.9yrs

Jüngste Management Updates

Recent updates

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

Jul 20
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Jun 23
We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Jun 10
Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Curt Hartman im Vergleich zu den Einnahmen von CONMED verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

US$82m

Dec 31 2023US$8mUS$950k

US$64m

Sep 30 2023n/an/a

US$58m

Jun 30 2023n/an/a

US$88m

Mar 31 2023n/an/a

-US$94m

Dec 31 2022US$8mUS$946k

-US$81m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

US$68m

Dec 31 2021US$9mUS$918k

US$63m

Sep 30 2021n/an/a

US$62m

Jun 30 2021n/an/a

US$54m

Mar 31 2021n/an/a

US$13m

Dec 31 2020US$6mUS$888k

US$10m

Sep 30 2020n/an/a

US$311k

Jun 30 2020n/an/a

US$431k

Mar 31 2020n/an/a

US$34m

Dec 31 2019US$6mUS$842k

US$29m

Sep 30 2019n/an/a

US$29m

Jun 30 2019n/an/a

US$28m

Mar 31 2019n/an/a

US$31m

Dec 31 2018US$5mUS$791k

US$41m

Sep 30 2018n/an/a

US$72m

Jun 30 2018n/an/a

US$73m

Mar 31 2018n/an/a

US$71m

Dec 31 2017US$3mUS$753k

US$55m

Vergütung im Vergleich zum Markt: CurtDie Gesamtvergütung ($USD7.76M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.67M).

Entschädigung vs. Einkommen: CurtDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Curt Hartman (60 yo)

9.9yrs

Amtszeit

US$7,764,615

Vergütung

Mr. Curt R. Hartman has been Chairman of the Board at CONMED Corporation since May 21, 2020. Mr. Hartman has been the Chief Executive Officer and President of CONMED Corporation since November 09, 2014. Mr...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Curt Hartman
Chairman of the Board9.9yrsUS$7.76m0.29%
$ 5.9m
Todd Garner
Executive VP of Finance & CFO6.4yrsUS$2.87m0.00074%
$ 15.4k
Patrick Beyer
Chief Operating Officerless than a yearUS$3.30m0.035%
$ 729.5k
Stanley Peters
President of Advanced Surgical & Advanced Endoscopic Technologies9.4yrsUS$2.00m0.0048%
$ 100.4k
Richard Glaze
Chief Information Officerno datakeine Datenkeine Daten
Peter Shagory
Executive Vice President of Strategy & Corporate Development9.1yrskeine Daten0.012%
$ 250.5k
Shanna Cotti-Osmanski
Executive VP of Information Technology & CIO4.3yrskeine Datenkeine Daten
John Ferrell
Executive Vice President of Human Resources1.5yrskeine Daten0.0023%
$ 47.4k
Daniel Jonas
Special Counsel & Corporate Secretary6.1yrsUS$1.55m0.044%
$ 908.8k
David Murray
President of ConMed Electrosurgery19.9yrsUS$572.33kkeine Daten
Terence Berge
VP & Corporate Controller9.2yrskeine Daten0.0033%
$ 67.8k
Johonna Pelletier
VP of Tax & Treasurer9.2yrskeine Daten0.0043%
$ 89.0k

9.1yrs

Durchschnittliche Betriebszugehörigkeit

55.5yo

Durchschnittliches Alter

Erfahrenes Management: CNMDDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (9.1 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Curt Hartman
Chairman of the Board10.3yrsUS$7.76m0.29%
$ 5.9m
John Workman
Independent Director8.9yrsUS$257.37k0.066%
$ 1.4m
David Bronson
Independent Director8.9yrsUS$264.87k0.054%
$ 1.1m
Brian Concannon
Independent Director10.9yrsUS$257.37k0.031%
$ 650.5k
LaVerne Council
Independent Director4.5yrsUS$257.37k0.012%
$ 241.0k
Martha Aronson
Lead Independent Director8.3yrsUS$292.37k0.045%
$ 939.1k
Charles Farkas
Independent Director9.9yrsUS$249.87k0.065%
$ 1.3m
Barbara Schwarzentraub
Independent Director4.8yrsUS$264.87k0.017%
$ 358.2k

8.9yrs

Durchschnittliche Betriebszugehörigkeit

64yo

Durchschnittliches Alter

Erfahrener Vorstand: CNMDDie Vorstandsmitglieder gelten als erfahren (8.9 Jahre durchschnittliche Amtszeit).